Press release
Scopolamine Market Size, Share, Trends, Analysis and Forecast 2020-2026
A full report of Global Scopolamine Market is available at https://www.omrglobal.com/industry-reports/scopolamine-market
Increase in the frequent traveling among people is directly proportional to the growth of the motion sickness drug market and so scopolamine market. Significant growth in the developed, as well as developing countries, was witnessed in the aviation market, and once the COVID-19 pandemic effect diminishes, similar growth is expected in the aviation market. For instance, as per the US Department of Transportation, the US airlines carried around 5.0% more passengers on domestic flights and around 3.1% more passengers on international flights in 2018 as compared to 2017. Around 233.6 million passengers on international flights to and from the US was a record high, exceeding the previous high set in 2017. Air travel growth in Asia-Pacific is expected to remain to continue due to which a significant growth in the scopolamine market is expected in Asia-Pacific during the forecast period. Rising medical tourism in countries such as India, Indonesia, and Thailand is also a major factor contributing to the scopolamine market in the region.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/scopolamine-market
Emerging countries such as China, India, Indonesia, and Vietnam are witnessing significant growth in the market. As per the World Bank, the total air passenger in during the period of 2014 and 2018 has witnessed a growth of 104% in Vietnam from 23 million in 2014 to 47 million in 2018. Similarly, India has witnessed a growth of around 100% as air passenger has increased from 82 million in 2014 to 164 million in 2018. Countries such as UK, Indonesia, UAE, and Saudi Arabia each have recorded an overall growth of more than 20% during the period of 2014-2018. Due to this, the demand for motion sickness drugs will be witnessed in the following countries.
Scopolamine is available in all three forms that are oral, injection, and patches. However, patches are widely accepted for the treatment of nausea and vomiting due to motion sickness. Some of the major players offering scopolamine drugs include Novartis AG, Boehringer Ingelheim International GmbH, Cadila Healthcare Ltd., Baxter International Inc., Myungmoon Pharm Co. Ltd., Alchem International Pvt. Ltd., Caleb Pharmaceuticals, Inc., Phytex Australia, Fine Chemicals Corp., Perrigo Company plc and others.
Global Scopolamine Market- Segmentation
By Type
• Scopolamine Butyl bromide
• Scopolamine Base
By Dosage Type
• Oral
• Patches
• Injections
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/scopolamine-market
Global Scopolamine Market– Segment by Region
North America
• United States
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
Company Profiles
• Alchem International Pvt. Ltd.
• Baxter International Inc.
• Boehringer Ingelheim International GmbH
• Cadila Healthcare Ltd.
• Caleb Pharmaceuticals, Inc.
• Fine Chemicals Corp.
• Guangzhou Hanfang Pharmaceutical Co., Ltd.
• Myungmoon Pharm Co. Ltd.
• Novartis AG
• Perrigo Co. plc
• Pfizer Inc.
• Phytex Australia
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit https://www.omrglobal.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Scopolamine Market Size, Share, Trends, Analysis and Forecast 2020-2026 here
News-ID: 2067928 • Views: …
More Releases from Orion Market Research
Pallets Market Is Expected to Exhibit Significant Growth Over 2031 / CABKA Group …
Pallets market is anticipated to grow at a considerable CAGR of 5.3% during the forecast period. Wooden pallets are standardized versions that are produced in many sizes and configurations to accommodate different handling equipment and cargoes. The increasing adoption of wood pallets in various countries including the US is the prominent factor for the market growth. According to Rose Pallet company, the United States industry harvests 42% of the annual…
Omega-3 Polyunsaturated Fatty Acids Market Update Report 2024| Industry Trends, …
Omega-3 polyunsaturated fatty acids Market is anticipated to grow at a CAGR of 10.3% during the forecast period. The market is mainly due to the significant consumption of omega-3 in dietary supplements and pharmaceutical industries from across the globe. Omega-3 fatty acids cannot be synthesized by the human body and it is an essential element to enhance metabolic activities such as cognitive and cardiovascular functions. As a result, the adoption…
Nano Silica Market Outlook 2024-2031: Trends and Opportunities/ Cabot Corp., Evo …
The global nano silica market is anticipated to grow at a CAGR of 6.9% during the forecast period (2024-2031). The growing use cases of nano silica in multiple industries such as electric vehicles, construction, healthcare, plastics, and rubber industry and growing demand from these industries is driving growth in the global nano silica market. For instance,
In July 2023, ClearCoat Roofing announced the development of a new nano silica solution to…
Miticide Market Increasing Demand, Growth Analysis and Future Outlook by 2031/ A …
Miticide Market are harmful agents which destroys the plants and trees in gardens, lawns, farms for both residential and commercial purpose. Mites grow in the plants and trees due to change in environmental conditions which includes increase in temperature and humidity. Miticides are being used to control the population of mites in various plants and trees. Global Miticides Market is estimated to grow with substantial rate owing to rising demand…
More Releases for Scopolamine
Scopolamine Market With Four Main Geographies And Their Countries
This research study on "Scopolamine market" reports offers the comparative assessment of Scopolamine market and consist of Historical data, Significance, statistical data, size & share, Market Price & Demand, Business overview, Market Analysis By Product and Market Trends by Key Players. This Scopolamine Market is Segmented in two type on the basis of type of materials and end-users. It has global market covered in all the regions, ranging to that…
Global Scopolamine Market Study 2015-2025, by Segment (Scopolamine Butylbromide, …
Scopolamine is a medication used in the treatment of motion sickness and postoperative nausea and vomiting. Scopolamine is used to prevent nausea and vomiting caused by motion sickness or from anesthesia given during surgery.
The global Scopolamine market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Download exclusive Sample of this report:…
Scopolamine Market CAGR, Key Players, Applications, Products and Regions
The Scopolamine market report gives CAGR value, Industry Chains, Upstream, Geography, End user, Application, Competitor analysis, SWOT Analysis, Sales, Revenue, Price, Gross Margin, Market Share, Import-Export, Trends and Forecast. The report also gives insight on entry and exit barriers of the industry.
The Scopolamine market report covers major Manufactures Centroflora-cms, Fine Chemicals Corporation, Phytex Australia, Alchem International, Guangzhou Hanfang, Alkaloids Corporation, Luyin.
Initially report provides information about Scopolamine Market Scenario, Development Prospect,…
Transdermal Scopolamine Market Evolution / Developments
A new study by Transparency Market Research (TMR) indicates that Novartis AG, alone, contributed nearly 41.0% of the overall revenue of the global transdermal scopolamine market in 2016. Other two torch bearers in the market, namely, GlaxoSmithKline Plc and Baxter International Inc., commanded a cumulative share of 49.0% in the same year. Even though, the number of small players in the market is less, the degree of competition within the…
Global Transdermal Scopolamine Market 2018 - Novartis, GlaxoSmithKline, Perrigo
The statistical surveying information incorporated into the Transdermal Scopolamine report is the aftereffect of significant essential and optional research exercises. The report fragments the global market for Transdermal Scopolamine based on makers, item compose, applications, and districts. In this report, each fragment is contemplated completely and measurements are introduced in detail. The report offers an exact outline of the global Transdermal Scopolamine advertise covering key factors, for example, drivers and…
Transdermal Scopolamine Market | Comprehensive Analysis and Future Estimations 2 …
A new study by Transparency Market Research (TMR) indicates that Novartis AG, alone, contributed nearly 41.0% of the overall revenue of The Global Transdermal Scopolamine Market in 2016. Other two torch bearers in the market, namely, GlaxoSmithKline Plc and Baxter International Inc., commanded a cumulative share of 49.0% in the same year. Even though, the number of small players in the market is less, the degree of competition within the…
